Skip to main content
. 2023 Aug 4;18:232. doi: 10.1186/s13023-023-02835-x

Table 2.

Comparison of patient-reported outcomes and HRQoL of patients with different regimens

Outcomes All patients, n = 373 On-demand treatment, n = 82 short-term prophylaxis treatment, n = 276 long-term prophylaxis treatment, n = 18
Annual bleeds, mean (SD) 32.8(46.4) 63.0(65.6) 25.2(35.9) 9.8(16.3)
Chronic pain, n (%)
 Never 111(29.8) 13(15.9) 87(31.9) 11(61.1)
 Occasionally 163(43.7) 33(40.9) 124(45.4) 6(33.3)
 Sometimes 75(20.1) 22(26.8) 52(19.0) 1(5.6)
 Frequently 23(6.2) 13(15.9) 10(3.7) 0(0.0)
 Always 1(0.3) 1(1.2) 0(0.0) 0(0.0)
Target joints, mean (SD) 0.7(1.5) 0.7(1.4) 0.7(1.5) 0.3(0.6)
Disability, n (%)
 No 353(94.6) 75(91.5) 260(95.2) 18(100.0)
 Yes 20(5.4) 7(8.5) 13(4.8) 0(0.0)
EQ-5D, mean (SD) 0.875(0.186) 0.804(0.255) 0.890(0.157) 0.952(0.125)
EQ-VAS, mean (SD) 78.06(23.82) 71.96(27.01) 79.25(22.64) 87.72(20.92)